NEW YORK, Aug. 19 - High Throughput Genomics today said it has sold Celgene one of its Omix Imager target- and drug-discovery platforms and ArrayPlate kits.
Terms of the deal also call for HTG to develop and supply genomic-profiling kits to be used in chemicogenomics and pharmacogenomics studies, HTG said.